Product overview
Vaccine type
Meningococcal ACYW-135 (conjugate vaccine)
Commercial Name
Nimenrix
Manofacturer
Pfizer Europe MA EEIG
Responsible NRA
European Medicines Agency
Country
Netherlands
Prequalification
Prequalification Status
Current
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Vial + Ampoule
Number of Doses
1
Diluent
0.9% Sodium Chloride
Route of Administration
Intramuscular
Shelf Life
48 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
Active: Carton of 50 vials (50 doses) [Dimensions: 17.9 x 9.2 x 4.3 cm]; Diluent: Carton of 50 vials (50 doses). [Dimensions: 17.9 x 9.2 x 4.3 cm]
Tertiary Packaging
Active: Box containing 36 cartons of 50 vials (1800 vial/1800 doses)[Dimensions: 60 x 50 x 47 cm]; Diluent: Box containing 36 cartons of 50 vials (1800 vials/1800 doses)[Dimensions: 39.3 x 29.8 x 28.3]
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
Active:14.2 Diluent: 14.2 cm3/dose (in secondary packaging)